Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04167995
Other study ID # FWA 000017
Secondary ID
Status Completed
Phase Early Phase 1
First received
Last updated
Start date June 9, 2020
Est. completion date October 30, 2021

Study information

Verified date December 2022
Source Ain Shams University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

ADHD is a neurodevelopmental disorder characterized by persistent symptoms of inattention and/or hyperactivity and impulsivity that are present before age 18. These symptoms must be evident across ADHD treatment is currently based on a multimodal approach with the combination of psychotherapy and pharmacotherapy, but no reliable markers of treatment response have been identified yet and 20-35% of subjects in clinical trials may have an inadequate response to the treatment The gut microbiome refers to the microbial ecosystem found in the gastrointestinal system of the human species Probiotics are a type of beneficial bacteria that improve health and facilitate intestinal microbial balance Increasing evidence suggests that the gut microbiota plays a key role in the gut-brain communication axis by influencing metabolism, inflammation, the hypothalamic-pituitary-adrenal axis, and neurotransmission multiple domains and cause Impairment in functioning in order to meet the diagnostic criteria for ADHD


Description:

All patients will be randomly distributed into two equal groups using a random number generator from computer-based randomization software. the probiotic group (n=40) received probiotic preparation twice daily (Lacteol Forte; Rameda, Egypt) as sachets containing 10 billion colony-forming units (CFU) of Lactobacillus fermentum and Lactobacillus delbruekii for 12 weeks added to a weight-dependent dose of standard treatment (Atomoxetine), and the 40 patients in the control group will not receive the probiotic and on a weight-dependent dose of atomoxetine.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date October 30, 2021
Est. primary completion date November 9, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Years to 16 Years
Eligibility Inclusion Criteria: - Age from 6 to 16 years old. - Children fulfilled DSM(V) Criteria for ADHD syndrome. Exclusion Criteria: - Intelligence quotient (IQ) less than 80% . - Presence of other medical conditions as chronic medical or neuropsychiatric disorders e.g diabetes mellitus, epilepsy…..etc. hearing or visual impairment, or medications side effects. - currently taking probiotics or antibiotics

Study Design


Intervention

Drug:
Probiotic Formula lacteal forte
Active Comparator: Patient with attention deficit hyperactive disorder patients (n=40) will receive probiotic preparation twice daily (Lacteol Forte; Rameda, Egypt) as sachets containing 10 billion colony forming units (CFU) of Lactobacillus fermentum and Lactobacillus delbruekii for 12 weeks .

Locations

Country Name City State
Egypt Reham Ibrahim Cairo

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Conner's Parent Rating Scales-Revised (CRS-R):for follow up This tool is used in order to assess the profile and severity of symptoms, response to treatment and follow up studies. Items are scored on 14 subscales of symptoms including opposition, cognitive problems, inattention, and hyperactivity.It is usually considered normal when T-scores are less than 60, while scores above 60 are signs of academic, behavioral, or social issues. There are several different classes as well 3 months
Primary Child behavior checklist Parent form to asses the associated internalizing and externalizing behaviour 3 months
Secondary Conners Continuous Performance Test (CPT) To asses sustained attention and impulsivity 3 months
Secondary Wisconsin (Berg) Card Sort Test (WCST) To evaluate executive function 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT03886025 - Combined Anodal Transcranial Direct Current Stimulation (tDCS) and Cognitive Training and Decision-making N/A
Recruiting NCT03457402 - Shaping Tolerance for Delayed Rewards N/A
Recruiting NCT05383989 - The UniVenture Program N/A
Completed NCT01976156 - The Gut-brain Axis: a Novel Target for Treating Behavioral Alterations in Obesity N/A
Completed NCT01978431 - Impulsivity and Stimulant Administration Phase 1
Completed NCT02930642 - Food Insecurity, Obesity, and Impulsive Food Choice N/A
Completed NCT04405089 - tDCS for Impulsivity and Compulsivity in Obesity N/A
Recruiting NCT05647044 - Frontal iTBS for Impulsivity and Suicidal Ideation in Veterans With Mild Traumatic Brain Injury Phase 1
Completed NCT01902069 - The Gut-brain Axis in Food Reward and Alcohol Consumption N/A
Recruiting NCT05231213 - Effects of Neuromodulation and Cognitive Training for Suicide in Veterans (ENACTS) N/A
Active, not recruiting NCT03844607 - Combined tDCS and Cognitive Training to Reduce Impulsivity in Patients With Traumatic Brain Injury N/A
Completed NCT05863169 - fNIRS Neurofeedback in Highly Impulsive Participants With ROI Regions DLPFC and IFG N/A
Active, not recruiting NCT01314378 - Effects of Intensive Behavioral Training Program on Impulsivity and Inhibitory Control in Smokers N/A
Completed NCT01982422 - Developmental Origins of Attention Deficit Hyperactivity Disorder N/A
Recruiting NCT06129500 - CBT for Problematic Impulsive Behaviours in Bipolar Disorder: A Case Series / CBT-PIB N/A
Completed NCT03623477 - Can Cognitive Training Decrease Reactive Aggression? N/A
Recruiting NCT05324670 - Title: "Intervention Based on Didactic Model for Suicidal Behavior in the Framework of Impulsivity and Ideations." N/A
Withdrawn NCT01770600 - Impulsivity and Thought Process Disorder in Patients With Active Suicidal Ideation and Depression N/A
Terminated NCT04781166 - An Online Intervention to Reduce Self-Harm Among Persons With High Emotion-Related Impulsivity N/A